Over the past 20 years, the Sir Jules Thorn Trust has supported world-leading translational research projects through the annual Sir Jules Thorn Award. The Trust is conscious of the disruption that the pandemic has caused to research across universities and the NHS, and the impact that the pandemic has had on other sources of research funding. The Trust is now making up to £1 million available to support an additional, one-off research award in 2021. The Trustees wish to use the award to support a single, outstanding research project, in any discipline or disease area, which is at an advanced stage of translation and is able to demonstrate a clear pathway to translate research findings into benefit for patients.
Remit
The scope of this award is deliberately broad and is not focused on any specific discipline or disease area. Applications might therefore include proposals which could lead to improved diagnosis and/or prognostic methods and to new treatments.
The award is intended to support research where the Applicant’s team has already generated data or samples to proceed to the next stage of their work and is now seeking funding to translate the research into clinical outcomes. Therefore, applications should focus on research at an advanced stage of translation.
For more information please see the Guidance Notes for this scheme.
Eligibility
Applications for the award are open to UK medical schools and NHS organisations. Each eligible institution/organisation may only submit one application.
The proposed research must have a justifiable claim to be at the leading edge of international science and must be led by a clearly identified Principal Applicant.
The Principal Applicant must hold an institutionally-funded post for the duration of the grant, as the award may not be used to meet their salary costs.
